Announcement
19 Sep 2024
In September 2024, US BARDA awarded USD 29 million to Basilea Pharmaceutica to develop two antifungal therapeutics targeting drug-resistant invasive fungal infections.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
19 Sep 2024
Revocation date:
No revocation date
Updated: 19 Sep 2024
State aid, unspecified
In force
On 19 September 2024, the Biomedical Advanced Research and Development Authority (BARDA) announced a USD 29 million award to Basilea Pharmaceutica International Ltd for the development of two antif...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.